Literature DB >> 31179565

Remission after complete excision of an intramedullary hemangioma with an identifiable tumor plane in a dog.

Amy B Yanke1,2, Margaret A Miller3, Caroline V Fulkerson1, Kendra Bohn4, R Timothy Bentley1.   

Abstract

OBJECTIVE: To describe the use of an identifiable tumor plane (ITP) during myelotomy to excise an intramedullary hemangioma in a dog and report the outcome. STUDY
DESIGN: Case report. ANIMALS: One 5.5-year-old 42.9-kg spayed female Leonberger dog.
METHODS: Clinical signs included progressive proprioceptive deficits of both pelvic limbs. Magnetic resonance imaging was consistent with a dorsal intramedullary mass at L3-L4. A laminectomy of the third and fourth lumbar vertebrae provided access for dorsal myelotomy. A clear surgical ITP was identified between the intramedullary mass and the spinal cord facilitating complete surgical resection.
RESULTS: Histopathological examination was consistent with a hemangioma. Postoperative MRI was consistent with complete excision of the mass. No evidence of recurrence was found by MRI at 3 months and at 22 months after surgery. Mild proprioceptive deficits persisted in the right pelvic limb.
CONCLUSION: A clear ITP was present, and gross-total resection (GTR) was achieved without significant morbidity. Persistent clinical remission resulted from surgery as the sole therapy. CLINICAL SIGNIFICANCE: For an intramedullary tumor, GTR is the absence of visible tumor on intraoperative inspection combined with the absence of intramedullary contrast enhancement on postoperative MRI. When an ITP is present, GTR and resultant long-term remission may be more likely.
© 2019 The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2019        PMID: 31179565     DOI: 10.1111/vsu.13238

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  1 in total

1.  Intracranial Virotherapy for a Canine Hemangioma.

Authors:  Pablo Delgado-Bonet; Beatriz Davinia Tomeo-Martín; Blanca Delgado-Bonet; David Sardón-Ruiz; Angel Torrado-Carvajal; Isidro Mateo; Ana Judith Perisé-Barrios
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.